Skip to main content

Table 4 Mean and standard deviation of payments, by treatment modality

From: The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid

  TOTAL OC/OP/SG Cancer Known Treatment Modalities Unknown P-valueB
   Radiation Surgery Chemotherapy Radiation + Chemotherapy Surgery + Chemotherapy Surgery + Radiation Surgery + Radiation + Chemotherapy TOTAL Known treatment modalities   
COMMERCIAL            
Number of enrollees 3,918 233 882 77 361 55 670 681 2959 959  
Total $ 79,151 105,422 32,476 79,072 137,315 137,277 110,679 153,892 99,822 15,373 <0.001
  (86,170) (82,487) (47,082) (72,498) (77,676) (125,408) (75,189) (92,759) (88,715) (25,828)  
Rx Drug $ 3,541 3,900 2,207 7,858 5,637 8,862 3,602 5,079 4,006 2,107 <0.001
  (5,487) (4,484) (3,725) (11,149) (6,560) (14,613) (4,883) (6,628) (5,996) (3,061)  
ER $ 723 1,614 330 637 1,641 495 1,035 805 871 265 <0.001
  (4,282) (6,465) (1,679) (1,624) (9,247) (1,127) (5,063) (3,571) (4,854) (1,403)  
Inpatient $ 20,691 18,778 15,950 20,623 24,166 51,659 28,778 38,334 26,017 4,257 <0.001
  (44,150) (43,736) (38,519) (31,899) (43,557) (95,505) (44,889) (60,405) (48,933) (14,789)  
Outpatient $ 54,197 81,130 13,989 49,954 105,871 76,260 77,264 109,674 68,927 8,745 <0.001
  (60,854) (61,492) (16,468) (52,256) (58,144) (84,987) (54,602) (57,678) (62,582) (17,619)  
MEDICARE            
Number of enrollees 2,303 130 660 53 150 69 434 281 1777 526  
Total $ 48,410 66,670 28,138 57,590 85,462 53,526 67,020 96,520 57,969 16,113 <0.001
  (61,599) (59,605) (47,551) (72,809) (72,710) (48,819) (61,044) (79,430) (65,926) (24,099)  
Rx Drug $ 3,798 4,362 3,232 6,056 4,332 6,400 3,622 5,102 4,006 3,096 <0.001
  (4,558) (5,284) (3,249) (5,723) (4,428) (6,749) (3,918) (4,932) (4,323) (5,220)  
ER $ 259 396 175 729 461 294 232 423 289 157 <0.001
  (898) (966) (453) (1,868) (983) (574) (1,270) (1,160) (981) (517)  
Inpatient $ 12,863 10,860 12,240 15,576 15,527 12,597 17,417 20,164 15,047 5,483 <0.001
  (29,872) (24,140) (31,434) (42,028) (34,848) (16,582) (32,743) (35,304) (32,264) (17,905)  
Outpatient $ 31,490 51,051 12,492 35,230 65,141 34,235 45,750 70,831 38,627 7,378 <0.001
  (43,870) (45,289) (25,229) (46,680) (51,534) (40,263) (42,711) (59,425) (47,302) (10,725)  
MEDICAID            
Number of enrollees 585 52 93 29 70 7 62 68 381 204  
Total $ 59,404 73,861 49,526 37,556 114,761 152,220 68,332 107,287 79,178 22,474 <0.001
  (74,919) (79,958) (76,721) (50,914) (108,040) (126,234) (57,119) (59,904) (82,735)   
Rx Drug $ 5,254 4,612 4,063 4,936 12,224 19,478 4,306 6,159 6,401 3,113 <0.001
  (7,614) (5,556) (5,309) (6,440) (14,169) (21,473) (4,612) (4,571) (8,770)   
ER $ 1,119 584 784 537 820 663 480 864 707 1,889 <0.001
  (11,530) (1,021) (1,491) (1,045) (1,389) (855) (748) (1,697) (1,318)   
Inpatient $ 28,954 38,564 35,280 13,464 50,024 111,605 28,326 45,878 38,939 10,305 <0.001
  (62,084) (71,797) (72,032) (38,892) (101,144) (122,921) (51,091) (54,231) (72,752)   
Outpatient $ 24,078 30,101 9,399 18,620 51,694 20,474 35,220 54,386 33,132 7,168 <0.001
  (28,650) (20,080) (7,624) (20,389) (35,506) (13,681) (24,433) (36,987) (31,159)   
  1. A. Total known modalities is the sum of previous 7 columns (radiation through surgery + radiation + chemotherapy.
  2. B. P-value is from chi square test for a significant difference between the treatment modalities (including unknown modality).
  3. Adjusted to 2009$.